Overprescription of short-acting β2-agonists is associated with poor asthma symptom control: results from five Middle Eastern countries included in the SABINA International (III) study
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2022.2099841
Abstract: ABSTRACT Background Although short-acting β2-agonist (SABA) overuse is associated with poor treatment outcomes, data on SABA use in the Middle East are lacking. Research design and methods In this cross-sectional study in patients (aged ≥12… read more here.
Keywords: saba; overprescription; saba prescriptions; short acting ... See more keywords